Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...
"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits ...
Amgen Inc. said Monday it had agreed to sell two of its smaller drugs and license a third to Swedish drugmaker Biovitrum AB in a deal valued at $130 million. Stockholm-based Biovitrum will acquire ...
THOUSAND OAKS, Calif. and TOKYO, Sept. 8, 2025 /PRNewswire/ -- Amgen (AMGN) and Kyowa Kirin Co., Ltd. (TSE: 4151) today announced preliminary top-line results from the ASCEND study evaluating ...
AMGN stock is in focus ahead of Q4 earnings, with biosimilar pressure and newer drug growth shaping expectations for the ...
Amgen AMGN delivered yet another strong quarterly performance. Its second-quarter 2025 earnings and sales beat estimates. The company has been recording consistently strong top-line performance. Amgen ...
Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS of $5 ...
NEW YORK (Reuters) - U.S. biotechnology company Amgen Inc is expanding in Brazil, announcing on Friday it had acquired privately-held Bergamo for about $215 million while reacquiring rights in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results